Page last updated: 2024-10-17

aminocaproic acid and Compartment Syndromes

aminocaproic acid has been researched along with Compartment Syndromes in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Compartment Syndromes: Conditions in which increased pressure within a limited space compromises the BLOOD CIRCULATION and function of tissue within that space. Some of the causes of increased pressure are TRAUMA, tight dressings, HEMORRHAGE, and exercise. Sequelae include nerve compression (NERVE COMPRESSION SYNDROMES); PARALYSIS; and ISCHEMIC CONTRACTURE. FASCIOTOMY is often used to decompress increased pressure and eliminate pain associated with compartment syndromes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jy, W1
Gagliano-DeCesare, T1
Kett, DH1
Horstman, LL1
Jimenez, JJ1
Ruiz-Dayao, Z1
Santos, ES1
Ahn, YS1

Other Studies

1 other study available for aminocaproic acid and Compartment Syndromes

ArticleYear
Life-threatening bleeding from refractory acquired FVIII inhibitor successfully treated with rituximab.
    Acta haematologica, 2003, Volume: 109, Issue:4

    Topics: Aged; Aged, 80 and over; Aminocaproic Acid; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-D

2003